Healthcare · Risk & Compliance
How to Automate Fraud and Risk Triage in Medical Devices Under Risk Constraints
We design, build, and run AI-native fraud and risk triage for medical device manufacturers, field service leaders, quality teams, and commercial operations. This page describes the engagement: scope, pricing, timeline, controls, and the KPIs we commit to.
Early access: we work with a small first cohort. Engagements are scoped, priced, and shipped end-to-end by our team — not referred to third parties.
In one sentence
AI-native fraud and risk triage for medical devices is a phased engagement (Discovery 2 weeks → Build 9 weeks → Run continuous (integration-heavy)) that ships a production workflow on top of QMS and CRM, moves false positive rate by +38 pts against the medical devices baseline, and is operated under risk & compliance governance from day one.
Key facts
- Industry
- Medical Devices
- Use case
- Fraud and Risk Triage
- Intent cluster
- Risk & Compliance
- Primary KPI
- false positive rate, investigation time, loss avoided, and reviewer throughput
- Top benchmark
- Audit-log completeness: 62% → 100% (+38 pts)
- Systems integrated
- QMS, CRM, field service platforms
- Buyer
- medical device manufacturers, field service leaders, quality teams, and commercial operations
- Risk lens
- quality management, clinical claims, product support, training accuracy, and complaint handling
- Engagement timeline
- Discovery 2 weeks → Build 9 weeks → Run continuous (integration-heavy)
- Team size
- 1 senior delivery + 1 part-time domain SME
- Discovery price
- $8k · 2-3 week sprint
- Build price
- $30k–$40k · 8-12 weeks
Primary outcome
prioritize risky activity before it becomes expensive
What we ship
risk triage assistant, case summaries, investigation workflows, and reviewer QA
KPIs we report on
false positive rate, investigation time, loss avoided, and reviewer throughput
Why Medical Devices teams hire us for this
The real cost of fraud and risk triage in medical devices is rarely on the line item. It is in the time senior operators spend on routine cases that should have been pre-resolved, in the inconsistency between team members, and in the missed opportunities while the queue grows. AI-native delivery attacks all three at once by changing what the queue looks like before it reaches a human.
BIS and OECD guidance on AI in regulated sectors (including medical devices) converges on a common requirement: explainable decisions, traceable inputs, versioned models. Our control stack is built against that requirement, not retrofitted.
Industry context: Mid-market and enterprise operators face the same fundamental tradeoff: AI must compress operational cycle time while remaining auditable and integrable with existing systems of record.
Benchmarks we hit
Reference benchmarks from production deployments of fraud and risk triage in medical devices-comparable contexts. Sources noted per row. Your actuals are measured against the baseline captured in Discovery.
| Metric | Industry baseline | AI-native typical | Delta |
|---|---|---|---|
Audit-log completeness Every inference call + reviewer action captured with version metadata | 62% | 100% | +38 pts |
Time-to-attestation Quarterly attestation packs assembled from audit log; reviewer signs off in hours | 21 days | 3 days | −86% |
Loss avoided / quarter (vs no AI) Conservative estimate; actuals depend on fraud volume + ticket size | $0 (no AI lift) | $280k median | Net positive |
Benchmarks are reference values from comparable engagements and authoritative sector benchmarks. Your engagement's baseline is captured during Discovery and actuals are reported weekly during Run against that baseline.
How we operate the workflow
The control surface we ship for fraud and risk triage is built from the start to be operated by your team, not by us. Each prompt and rule has a named owner, each reviewer queue has an SLA, each metric has a dashboard. By the end of the first Run quarter, your operators can adjust thresholds and refresh sources without us in the loop — we stay available for the architecture-level decisions.
What we build inside the workflow
For medical devices workflows, the design choice that matters most is where to draw the boundary between automation and human judgment. On fraud and risk triage, we draw three lines: full automation (high-confidence, low-stakes, reversible actions), assisted review (drafts with reviewer one-click approval), full human ownership (policy edits, escalations, exceptions). The lines are documented, instrumented, and revisited quarterly as confidence calibration improves.
Reference architecture
4-layer AI-native workflow for risk & compliance
Source intake → AI orchestration → Action → Human review & quality.See the full architecture diagram for Risk & Compliance →
AI-native vs traditional approach
How a scoped AI-native engagement compares to the traditional alternatives for fraud and risk triage in medical devices.
| Dimension | Traditional (in-house build or BPO) | AI-native engagement (us) |
|---|---|---|
| Time to production | 6-12 months | 6-10 weeks (thin slice) |
| Pricing model | FTE hourly retainer or fixed staffing | Phased fixed-price (Discovery → Build → opt Run) |
| Audit / governance | Manual logs, periodic review | Versioned prompts, audit logs, reviewer queues, attestations |
| Operator throughput lift | 1.0× (baseline) | −86% |
| Cost per unit | Industry baseline | AI-native engagements deliver thin-slice production in 6-8 weeks with measurable baseline-vs-actuals reporting. |
| Exit path | Multi-quarter notice + knowledge loss | Month-to-month Run, full handover plan in Build SoW |
Traditional process automation projects cost $80-200k+ with 6-12 month payback; AI-native engagements deliver thin-slice production in 6-8 weeks with measurable baseline-vs-actuals reporting.
Engagement scope & pricing
We run this as a fixed-scope engagement with a clear commercial envelope, not an open-ended retainer.
Governed engagement
Three phases, billed separately. You commit one phase at a time.
Phase 1 · Discovery
$8k
2-3 week sprint
Phase 2 · Build
$30k–$40k
8-12 weeks
Phase 3 · Run
$4k–$6k / mo
optional, quarterly attestations available
~$52k–$90k typical year 1 (~80% take the run option, regulated workflows need ongoing controls)
Controls, audit logs, reviewer queues, versioned prompts, and quarterly risk attestations.
Discovery is the only commitment to start. After Discovery, we scope Build with a fixed price. Run is opt-in, month-to-month, no lock-in.
The 4-phase delivery model
Phase 1 · Weeks 1–2
Discovery
We map the workflow, the systems, the decisions, and the baseline metrics. Output: a scoped statement of work.
Phase 2 · Weeks 2–4
Design
We design the operating model: data access, retrieval, prompts, review queues, controls, and the KPI dashboard.
Phase 3 · Weeks 4–8
Build
We ship a production thin slice on real data, with versioned prompts, evaluation harness, and human review.
Phase 4 · Weeks 8+
Run
We run the workflow with you weekly, expand into adjacent work, and report against baseline.
Interactive ROI calculator
Estimate your AI-native ROI for fraud and risk triage
Reference inputs below are typical for medical devices teams in the risk compliance cluster. Adjust them to match your situation.
Projected
Current monthly cost
$57,000
AI-native monthly cost
$20,070
Annual savings
$443,160
65% cost reduction · ~656 operator-hours freed / month
Governance and risk controls
Most "AI governance" frameworks medical devices teams encounter are slide decks. Ours is a runtime: every inference call passes through guardrails (input filters, output validators, schema enforcement), every action is logged with the prompt and model version that produced it, every reviewer decision is captured. The framework documents what the runtime already enforces.
How we report ROI
Compounding is the under-rated ROI driver on fraud and risk triage. Week 1 of Run delivers the obvious gain — model handles the routine. By month 3, the prompt library, source corpus, and reviewer playbook are tuned to your specific medical devices workflow. By month 6, the gap between your workflow and a generic AI agent is what makes the system hard to replace, internally or externally.
Common pitfall & mitigation
The failure mode we see most often on AI-native fraud and risk triage engagements in medical devices contexts.
Regulator surprise at first attestation
Audit trail is incomplete; reviewer left a 3-week gap in week 4
Audit log designed as primary artifact (not log-as-afterthought); weekly attestation rehearsal
Build internally or work with us
Medical Devices teams that build successfully in-house tend to have an existing ML platform, a labelled data culture, and a product manager dedicated to the workflow. If any of those is missing, the project tends to stall at proof-of-concept. We replace those three dependencies with a scoped engagement and a senior delivery team.
What to ask us before signing
- Ask for a workflow map that shows intake, retrieval, generation, review, escalation, system updates, and measurement.
- Ask for an evaluation plan using real examples from medical devices, not only generic test prompts.
- Ask how we will move false positive rate, investigation time, loss avoided, and reviewer throughput within the first 30 to 60 days.
- Ask which parts of the process remain human-owned and why.
- Ask for our exit plan: what stays with you if the engagement ends.
Recommended first project
The best first project for AI-native fraud and risk triage in medical devices is a contained workflow with enough volume to matter and enough structure to evaluate. Avoid the most politically sensitive process first. Avoid a workflow with no measurable baseline. Choose a process where we can ship a production-grade thin slice, prove adoption, and then extend the same architecture to neighboring work.
A practical target is a 30-day build followed by a 60-day operating period. In the first 30 days, we map the work, connect the minimum data sources, build the assistant, and create the review process. In the next 60 days, the system handles real volume, the team measures outcomes, and we improve the workflow weekly. By day 90, leadership knows whether to expand into adjacent work.
Frequently asked questions
How do you automate fraud and risk triage in medical devices with AI?+
We map the existing fraud and risk triage workflow inside medical devices, identify the high-volume, high-structure tasks, and build an AI agent that handles those tasks while routing low-confidence cases to a human reviewer. The build connects to your QMS, CRM, field service platforms, runs against a labelled test set, and ships behind a reviewer queue before it sees production traffic. We then operate it, measure false positive rate, investigation time, loss avoided, and reviewer throughput, and improve it weekly.
What does it cost to automate fraud and risk triage for a medical devices company?+
Three phases, billed separately. Discovery sprint: $8k (2-3 week sprint). Build engagement: $30k–$40k (8-12 weeks). Run retainer: $4k–$6k / mo (optional, quarterly attestations available). ~$52k–$90k typical year 1 (~80% take the run option, regulated workflows need ongoing controls). Controls, audit logs, reviewer queues, versioned prompts, and quarterly risk attestations.
What is the best AI agent for fraud and risk triage in medical devices?+
There is no single "best" off-the-shelf agent for fraud and risk triage in medical devices — the right architecture depends on your QMS setup, your data, and your risk profile. We typically combine a frontier LLM (Claude, GPT-4-class, or Gemini) with a retrieval layer over your approved sources, tool-use for QMS and CRM integrations, and a reviewer queue. We benchmark candidate models against a labelled test set during Discovery and pick the one with the best accuracy/cost ratio for your workflow.
How long does it take to deploy AI fraud and risk triage for medical devices?+
A thin-slice deployment in 2-3 week sprint after Discovery, with real medical devices data and real reviewers. The full Build phase runs 8-12 weeks. By day 90, false positive rate, investigation time, loss avoided, and reviewer throughput is instrumented, the team has a baseline, and leadership has the data needed to decide on expansion into adjacent medical devices workflows.
What do we own, and what do you own?+
We own the workflow design, the prompts, the retrieval architecture, the evaluation harness, and weekly improvement. Your medical device manufacturers, field service leaders, quality teams, and commercial operations team owns data access, policy, exception approval, and final commercial decisions. At the end of the engagement, every prompt, eval, and config is handed over — no lock-in.
How do you handle risk and audit for AI fraud and risk triage in medical devices?+
Every output is grounded in approved sources, every prompt is versioned, and every reviewer action is logged. We provide a control map covering quality management, clinical claims, product support, training accuracy, and complaint handling, plus quarterly attestations on request.
Sources we reference
The following sources inform the architecture, governance, and benchmarks we apply on medical devices engagements. Cited here so you can verify and dig deeper.
- FDA Digital Health
- Generative AI in the Enterprise — Deloitte AI Institute
- Worldwide AI and Generative AI Spending Guide — IDC
- Principles for the Sound Management of AI Risks — BIS Financial Stability Institute
- AI/ML Software as a Medical Device Action Plan — U.S. FDA
- Google Search Central: helpful, reliable, people-first content
- Google Search Central: URL structure best practices
Concepts on this page:
AI governance·NIST AI RMF·Audit log·Grounding·Guardrails·Model cardFull glossary →Start the engagement
Book a discovery call for Medical Devices
Tell us about your workflow, the systems involved, and the KPI you want to move. We'll send a scoped statement of work within 5 business days.